M-ESOMEPRAZOLE

mantra pharma inc🇨🇦 Health Canada

Approval Id: b7f2215e0da8e5b1
Drug Approval Canada Name: M-ESOMEPRAZOLE
Product Name: M-ESOMEPRAZOLE
Status: Marketed
Status Date: 2022-03-16
Original Market Date: 2022-03-16
Din: 02520109
Drug Class: Human
Dosage Form: Tablet (Delayed-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 56:28.36
Atc Original: A02BC05 ESOMEPRAZOLE
Atc Name: a 02 bc 05
Aig Number: 0145162001
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b7f2215e0da8e5b1

Type

Standard